Nuvation Bio earnings were -$146.0M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest NUVB earnings report on Mar 31, 2026 announced Q1 2026 earnings of $5.4M, down 114.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, NUVB reported annual earnings of -$204.6M, with -64% growth. The next NUVB earnings date is Aug 6, 2026.
On NUVB's earnings call on May 19, 2026, Nuvation Bio (NYSE: NUVB) reported Q1 2026 earnings per share (EPS) of $0.02, up 112.5% year over year. Total NUVB earnings for the quarter were $5.40 million. In the same quarter last year, Nuvation Bio's earnings per share (EPS) was -$0.16.
The next NUVB earnings date is Aug 6, 2026. Add NUVB to your watchlist to be reminded of Nuvation Bio's next earnings date.
Is Nuvation Bio profitable or losing money?
As of the last Nuvation Bio earnings report, Nuvation Bio is currently losing money. Nuvation Bio's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$145.99 million, a 75.92% decrease year over year.
What was NUVB's earnings growth in the past year?
As of Nuvation Bio's earnings date in May 19, 2026, Nuvation Bio's earnings has grown year over year. NUVB earnings in the past year totalled -$145.99 million.
What are Nuvation Bio's earnings expectations?
The current EPS estimate for Nuvation Bio's earnings report in Aug 6, 2026 is -$0.15.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.